Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Recurrent Head and Neck Squamous Cell Carcinoma · Recurrent Hypopharyngeal Squamous Cell Carcinoma · Recurrent Laryngeal Squamous Cell Carcinoma · Recurrent Oral Cavity Squamous Cell Carcinoma · Recurrent Oropharyngeal Squamous Cell Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-686-8274
    Contact: Principal Investigator (Omar T. Atiq)
  • Kaiser Permanente-Anaheim, Anaheim, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Aakash Batra)
  • Kaiser Permanente-Bellflower, Bellflower, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Aakash Batra)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Shirin Attarian)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

  • Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Aakash Batra)
  • Kaiser Permanente-Ontario, Ontario, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Aakash Batra)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Shirin Attarian)
  • Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States

  • Sutter Roseville Medical Center, Roseville, California, United States

  • California Protons Cancer Therapy Center, San Diego, California, United States

  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Aarti Bhatia)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Aarti Bhatia)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Aarti Bhatia)
  • Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Aarti Bhatia)
  • MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-877-8839
    Contact: Principal Investigator (Cristina Merkhofer)
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Elizabeth A. Nicolli)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Elizabeth A. Nicolli)
  • UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Elizabeth A. Nicolli)
  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Elizabeth A. Nicolli)
  • Moffitt Cancer Center-International Plaza, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Kedar Kirtane)
  • Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Kedar Kirtane)
  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Kedar Kirtane)
  • Moffitt Cancer Center at Wesley Chapel, Wesley Chapel, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Kedar Kirtane)
  • Emory Proton Therapy Center, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · allyson.anderson@emory.edu · 404-251-2854
    Contact: Principal Investigator (James E. Bates)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (James E. Bates)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

  • Memorial Health University Medical Center, Savannah, Georgia, United States

  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Jochen H. Lorch)
  • John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-864-5204
    Contact: Principal Investigator (Deimante M. Tamkus)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Ameen Salahudeen)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Loyola University Medical Center, Maywood, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-226-4357
    Contact: Principal Investigator (Joseph I. Clark)
  • HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • The Carle Foundation Hospital, Urbana, Illinois, United States

  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • Reid Health, Richmond, Indiana, United States

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 712-322-4136
    Contact: Principal Investigator (Yungpo B. Su)
  • Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · kathryn.bartz@nmhs.org · 402-354-7939
    Contact: Principal Investigator (Yungpo B. Su)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Lutheran Hospital, Des Moines, Iowa, United States

  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Methodist West Hospital, West Des Moines, Iowa, United States

  • University of Kansas Cancer Center, Kansas City, Kansas, United States

  • University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States

  • University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States

  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

  • University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 859-257-3379
    Contact: Principal Investigator (Susanne M. Arnold)
  • The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 502-562-3429
    Contact: Principal Investigator (Neal E. Dunlap)
  • UofL Health Medical Center Northeast, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · ctoinfo@louisville.edu · 502-852-2755
    Contact: Principal Investigator (Neal E. Dunlap)
  • Maryland Proton Treatment Center, Baltimore, Maryland, United States

  • University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 800-888-8823
    Contact: Principal Investigator (Matthew J. Ferris)
  • Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 443-546-1300
    Contact: Principal Investigator (Matthew J. Ferris)
  • UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 410-553-8100
    Contact: Principal Investigator (Matthew J. Ferris)
  • Tufts Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · ContactUsCancerCenter@TuftsMedicalCenter.org · 617-636-5000
    Contact: Principal Investigator (Francis W. Nugent)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

  • Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

  • Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • University of Mississippi Medical Center, Jackson, Mississippi, United States

  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

  • University of Kansas Cancer Center - North, Kansas City, Missouri, United States

  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

  • University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States

  • Mercy Hospital Springfield, Springfield, Missouri, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-334-4773
    Contact: Principal Investigator (Yungpo B. Su)
  • Nebraska Methodist Hospital, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-354-5144
    Contact: Principal Investigator (Yungpo B. Su)
  • Oncology Associates PC, Omaha, Nebraska, United States

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Michael Hwang)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Michael Hwang)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Michael Hwang)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Michael Hwang)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Michael Hwang)
  • Mount Sinai Union Square, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Richard L. Bakst)
  • Mount Sinai Chelsea, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Richard L. Bakst)
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Richard L. Bakst)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Michael Hwang)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Monaliben Patel)
  • Stony Brook University Medical Center, Stony Brook, New York, United States

    Contact: Study coordinator (Site Public Contact) · 800-862-2215
    Contact: Principal Investigator (Amna Sher)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Rafi Kabarriti)
  • Montefiore Medical Center - Moses Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Rafi Kabarriti)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Michael Hwang)
  • Wilmot Cancer Institute at Webster, Webster, New York, United States

    Contact: Study coordinator (Site Public Contact) · WCICTOresearch@urmc.rochester.edu
    Contact: Principal Investigator (Monaliben Patel)
  • Randolph Hospital, Asheboro, North Carolina, United States

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Colette Shen)
  • Cone Health Cancer Center, Greensboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Vinay K. Gudena)
  • Annie Penn Memorial Hospital, Reidsville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Vinay K. Gudena)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • Indu and Raj Soin Medical Center, Beavercreek, Ohio, United States

  • Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States

  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · TaussigResearch@ccf.org · 866-223-8100
    Contact: Principal Investigator (Jessica L. Geiger)
  • Premier Blood and Cancer Center, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-276-8320
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physician LLC - Englewood, Dayton, Ohio, United States

  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physicians LLC-Atrium, Franklin, Ohio, United States

  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Greater Dayton Cancer Center, Kettering, Ohio, United States

  • Kettering Medical Center, Kettering, Ohio, United States

  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 877-231-4440
    Contact: Principal Investigator (Minh Phan)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Minh Phan)
  • Clackamas Radiation Oncology Center, Clackamas, Oregon, United States

  • Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States

  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • UPMC Altoona, Altoona, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Dan P. Zandberg)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Rajiv Panikkar)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Dan P. Zandberg)
  • UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ecog.rss@jimmy.harvard.edu
    Contact: Principal Investigator (Dan P. Zandberg)
  • IRMC Cancer Center, Indiana, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Dan P. Zandberg)
  • Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-374-8555
    Contact: Principal Investigator (Rajiv Panikkar)
  • UPMC Hillman Cancer Center - New Castle, New Castle, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Dan P. Zandberg)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jennifer M. Johnson)
  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 215-728-4790
    Contact: Principal Investigator (Thomas J. Galloway)
  • Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jennifer M. Johnson)
  • Temple University Hospital, Philadelphia, Pennsylvania, United States

  • UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-784-4900
    Contact: Principal Investigator (Dan P. Zandberg)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Dan P. Zandberg)
  • UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States

  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Dan P. Zandberg)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Rajiv Panikkar)
  • UPMC Memorial, York, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 717-724-6760
    Contact: Principal Investigator (Dan P. Zandberg)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Jennifer L. Harper)
  • Avera Cancer Institute, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3095
    Contact: Principal Investigator (Benjamin M. Solomon)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Avera Cancer Institute at Yankton, Yankton, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-655-1800
    Contact: Principal Investigator (Benjamin M. Solomon)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Jennifer H. Choe)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (Erin R. Alesi)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Erin R. Alesi)
  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Juli.Alford@aspirus.org · 715-623-9869
    Contact: Principal Investigator (Andrew J. Huang)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Matthias Weiss)
  • HSHS Sacred Heart Hospital, Eau Claire, Wisconsin, United States

  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-257-5100
    Contact: Principal Investigator (Stuart J. Wong)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Stuart J. Wong)
  • Drexel Town Square Health Center, Oak Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Stuart J. Wong)
  • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center, Rhinelander, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Aspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • Aspirus Cancer Care-Wausau, Wausau, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 877-405-6866
    Contact: Principal Investigator (Andrew J. Huang)
  • Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Stuart J. Wong)
  • Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 715-422-7718
    Contact: Principal Investigator (Andrew J. Huang)
מובילי המחקר
  • Dan P Zandberg

    Principal Investigator

    ECOG-ACRIN Cancer Research Group